0

CALDOLOR از شرکت CUMBERLAND PHARMS

تصویر پیدا نشد !

اطلاعات داروی نمایش داده شده مستقیما از دیتابیس اطلاعات دارویی سازمان غذا و دارو آمریکا (FDA) استخراج می شود و مرتبا به روز رسانی می شود
داروی نمایش داده شده مورد تایید FDA می باشد و اطلاعات ثبت آن در زیر قابل مشاهده است

CALDOLOR از شرکت CUMBERLAND PHARMS

New Drug Application (NDA): 022348

Company: CUMBERLAND PHARMS

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
CALDOLOR IBUPROFEN 400MG/4ML (100MG/ML) SOLUTION;INTRAVENOUS Discontinued

None

No No
CALDOLOR IBUPROFEN 800MG/8ML (100MG/ML) SOLUTION;INTRAVENOUS Prescription

None

Yes Yes
CALDOLOR IBUPROFEN 800MG/200ML (4MG/ML) SOLUTION;INTRAVENOUS Prescription

None

Yes Yes
Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
06/11/2009 ORIG-1 Approval

Type 5 – New Formulation or New Manufacturer

PRIORITY

Label (PDF)

Letter (PDF)

Review

Summary Review (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/022348lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2009/022348s000ltr.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/nda/2009/022348_caldolor_toc.cfm
https://www.accessdata.fda.gov/drugsatfda_docs/nda/2009/022348s000SumR.pdf

Supplements
Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels, Patient Package Insert Note Url
04/28/2021 SUPPL-18 Labeling-Package Insert

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022348s018lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/022348Orig1s018ltr.pdf

07/22/2019 SUPPL-14 Labeling-Package Insert

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022348s014lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/022348Orig1s014ltr.pdf

01/25/2019 SUPPL-13 Labeling-Container/Carton Labels, Labeling-Package Insert

Label is not available on this site.

05/09/2016 SUPPL-10 Labeling-Package Insert, Labeling-Package Insert, Labeling-Medication Guide

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/022348s010lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2016/022348Orig1s010ltr.pdf

11/20/2015 SUPPL-5 Efficacy-Pediatric

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/022348s005lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/022348Orig1s005ltr.pdf

03/09/2015 SUPPL-4 Manufacturing (CMC)

Label is not available on this site.

01/27/2015 SUPPL-3 Labeling-Container/Carton Labels

Letter (PDF)

Label is not available on this site.

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/022348Orig1s003ltr.pdf

01/14/2014 SUPPL-2 Manufacturing (CMC)

Label is not available on this site.

Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels,
Patient Package Insert
Note Url
04/28/2021 SUPPL-18

Labeling-Package Insert

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022348s018lbl.pdf
07/22/2019 SUPPL-14

Labeling-Package Insert

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022348s014lbl.pdf
05/09/2016 SUPPL-10

Labeling-Package Insert

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/022348s010lbl.pdf
05/09/2016 SUPPL-10

Labeling-Package Insert

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/022348s010lbl.pdf
05/09/2016 SUPPL-10

Labeling-Medication Guide

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/022348s010lbl.pdf
11/20/2015 SUPPL-5

Efficacy-Pediatric

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/022348s005lbl.pdf
06/11/2009 ORIG-1 Approval

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/022348lbl.pdf
حتما بخوانید : CALCIUM GLUCEPTATE از شرکت ABBOTT
برچسب‌ها:

نظرات کاربران